The risk groups for preventive medication against RSV have been confirmed
In Finland, nirsevimab will be offered to all children born during the 2024-2025 winter RSV epidemic and to those under three months of age when the epidemic starts.
This website is under construction. We are continuously adding more information in English. We apologize for the inconvenience this might cause and thank you for your patience.
